Status:
UNKNOWN
Establishing a New Ultrasound Technique to Improve Assessment of Chronic Kidney Disease.
Lead Sponsor:
University of Nottingham
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Blood flow to the kidneys is important in the development of kidney diseases. Currently we do not have ways of measuring and monitoring kidney blood flow for patients in real-time. This is a major bar...
Detailed Description
Renal perfusion, the delivery of oxygenated blood to kidney tissues, is relevant to a number of acute and chronic kidney diseases. Despite this, we do not have methods in current clinical practice to ...
Eligibility Criteria
Inclusion
- CKD 3b or CKD4
- Ability to give informed consent
Exclusion
- Autosomal dominant polycystic kidney disease
- Solid organ transplant
- Pregnant women
- Known allergy to Sonovue
- Contraindications to MRI
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 2 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06159439
Start Date
January 2 2024
End Date
February 2 2025
Last Update
December 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.